Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth

Molecular Human Reproduction

Volumn 21, Issue 4, 2014, Pages 369-381

  Li, Liping ^a   Yang, Jing ^a   Jiang, Yao ^a   Tu, Jiaoqin ^a   Schust, Danny J ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b University of Missouri   (United States)

Author keywords

Activation; Inflammation; Lipopolysaccharide; Natural killer T cells; Preterm birth

Indexed keywords

CD1D ANTIGEN; CD69 ANTIGEN; CELL RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR 4; CD1D ANTIGEN, MOUSE; LECTIN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; T LYMPHOCYTE ANTIGEN; TLR4 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELIVERY; DENDRITIC CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INVARIANT NATURAL KILLER T CELL; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STIMULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DECIDUA; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; NATURAL KILLER CELL; PATHOLOGY; PREGNANCY; PREMATURE BIRTH; TRANSPLANTATION;

MUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD; ANTIGENS, CD1D; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; COCULTURE TECHNIQUES; DECIDUA; DENDRITIC CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PREGNANCY; PREMATURE BIRTH; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84926472590     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gav001     Document Type: Article

References (42)

1. Akarsu ES, Mamuk S. Escherichia coli lipopolysaccharides produce serotype-specific hypothermic response in biotelemetered rats. Am J Physiol Regul Integr Comp Physiol 2007;292:R1846-R1850.
2. Bastek JA, Gómez LM, Elovitz MA. The role of inflammation and infection in preterm birth. Clin Perinatol 2011;38:385-406.
3. Bonham KS, Orzalli MH, Hayashi K, Wolf AI, Glanemann C,WeningerW, Iwasaki A, Knipe DM, Kagan JC. A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction. Cell 2014;156:705-716.
4. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 2013;13:101-117.
5. Brigl M, Brenner MB. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens. Semin Immunol 2010;22:79-86.
6. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003;4:1230-1237.
7. Brigl M, Tatituri RV, Watts GF, Bhowruth V, Leadbetter EA, Barton N, Cohen NR, Hsu FF, Besra GS, Brenner MB. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med 2011;208:1163-1177.
8. Buxadé M, Lunazzi G, Minguillón J, Iborra S, Berga-Bolaños R, Del Val M, Aramburu J, López-Rodríguez C. Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5. J Exp Med 2012;209:379-393.
9. De Santo C, Salio M, Masri SH, Lee LY, Dong T, Speak AO, Porubsky S, Booth S, Veerapen N, Besra GS et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 2008;118:4036-4048.
10. Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003;163:2103-2111.
11. Holmgren C, Esplin MS, Hamblin S, Molenda M, Simonsen S, Silver R. Evaluation of the use of anti-TNF-a in an LPS-induced murine model. J Reprod Immunol 2008;78:134-139.
12. Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, Akutsu Y, Kondo E, Sekiya S, Sekikawa K, Harada M et al. Involvement of decidual Va14 NKT cells in abortion. Proc Natl Acad Sci USA 2000;97:740-744.
13. Kim HS, Chung DH. IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner. Mucosal Immunol 2013;6:347-357.
14. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005;434:520-525.
15. KinjoY,Tupin E,WuD, Fujio M, Garcia-Navarro R, Benhnia MR, Zajonc DM, Ben-Menachem G, Ainge GD, Painter GF et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006;7:978-986.
16. Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, Li Y, ImamuraM, Kaneko Y, Okawara A et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 2011;12:966-974.
17. Kondo T, Kawai T, Akira S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol 2012;33:449-458.
18. Kronenberg M, Kinjo Y. Innate-like recognition of microbes by invariant natural killer T cells. Curr Opin Immunol 2009;21:391-396.
19. Li L, Fang Y, Dong G, Lin Y, Saito S. Depletion of invariantNKT cells reduces inflammation-induced preterm delivery in mice. J Immunol 2012; 188:4681-4689.
20. Lynch L, Nowak M, Varghese B, Clark J, Hogan AE, Toxavidis V, Balk SP, O'Shea D, O'Farrelly C, Exley MA. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012;37:574-587.
21. Makieva S, Saunders PT, Norman JE. Androgens in pregnancy: roles in parturition. Hum Reprod Update 2014;20:542-549.
22. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C III, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005;434:525-529.
23. Monteiro M, Almeida CF, Agua-Doce A, Graca L. Induced IL-17-producing invariant NKT cells require activation in presence of TGF-b and IL-1b. J Immunol 2013;190:805-811.
24. Nagarajan NA, Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 2007;178:2706-2713.
25. O'Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors- redefining innate immunity. Nat Rev Immunol 2013;13:453-460.
26. Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, Sheehan KC, Capron M, Ryffel B, Faveeuw C, Leite de Moraes M et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007;27:597-609.
27. Pellicci DG, Patel O, Kjer-Nielsen L, Pang SS, Sullivan LC, Kyparissoudis K, Brooks AG, Reid HH, Gras S, Lucet IS et al. Differential recognition of CD1d-alpha-galactosyl ceramide by the Vb8.2 and Vb7 semi-invariant NKT T-cell receptors. Immunity 2009;31:47-59.
28. Renneson J, Guabiraba R, Maillet I, Marques RE, Ivanov S, Fontaine J, Paget C, Quesniaux V, Faveeuw C, Ryffel B et al. A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection. Am J Pathol 2011;179:1872-1883.
29. Rogers L, Burchat S, Gage J, Hasu M, Thabet M, Willcox L, Ramsamy TA, Whitman SC. Deficiency of invariant Va14 natural killer T cells decreases atherosclerosis inLDL receptor nullmice. Cardiovasc Res 2008;78:167-174.
30. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce Interferon-g, and kill intracellular bacteria. PLoS Pathog 2008; 4:e1000239.
31. Salio M, Speak AO, Shepherd D, Polzella P, Illarionov PA, Veerapen N, Besra GS, Platt FM, Cerundolo V. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci USA 2007;104:20490-20495.
32. Tamura R, Kanda T, Imazeki F, Wu S, Nakamoto S, Tanaka T, Arai M, Fujiwara K, Saito K, Roger T et al. Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. J Infect Dis 2011;204:793-801.
33. Taniguchi M, Koseki H, Tokuhisa T, Masuda K, Sato H, Kondo E, Kawano T, Cui J, Perkes A, Koyasu S et al. Essential requirement of an invariant Va14T cell antigen receptor expression in the development of natural killerTcells. Proc Natl Acad Sci USA 1996;93:11025-11028.
34. Tyznik AJ, Tupin E, Nagarajan NA, Her MJ, Benedict CA, Kronenberg M. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J Immunol 2008;181:4452-4456.
35. Van Kaer L, Parekh VV,Wu L. Invariant natural killer T cells: bridging innate and adaptive immunity. Cell Tissue Res 2011;343:43-55.
36. Van Kaer L, Parekh VV,Wu L. Invariant natural killer T cells as sensors and managers of inflammation. Trends Immunol 2013;34:50-58.
37. Venkataswamy MM, Porcelli SA. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin Immunol 2010;22:68-78.
38. Wang X, Bishop KA, Hegde S, Rodenkirch LA, PikeJW, Gumperz JE. Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation. J Exp Med 2012;209:987-1000.
39. Wesley JD, Tessmer MS, Chaukos D, Brossay L. NK cell-like behavior of Va14i NK T cells during MCMV infection. PLoS Pathog 2008;4:e1000106.
40. WuL, Van Kaer L. Natural killerTcells in health and disease. Front Biosci 2011;3:236-251.
41. Xu S, Liu X, Bao Y, Zhu X, Han C,Zhang P,Zhang X, Li W,Cao X. Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway. Nat Immunol 2012;13:551-559.
42. Yang M, Wang C, Zhu X,Tang S, Shi L, Cao X,Chen T. E3 ubiquitin ligaseCHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC. J Exp Med 2011;208:2099-2112.